世界の医薬品温度管理包装市場は、2025年に6512百万米ドルと算定されており、2026年には7034百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）8.9%で推移し、2032年には11720百万米ドルに達すると予測されています。

本レポートは、医薬品温度管理包装メーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界の医薬品温度管理包装市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、医薬品温度管理包装に関する情報に基づいたビジネス判断を行うことを支援します。医薬品温度管理包装市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Sonoco Products Company
Envirotainer
Pelican Biothermal
Cryopak
DS Smith Pharma
Cold Chain Technologies
Intelsius
CSafe
Softbox Systems
Cencora
Skycell
Va-Q-tec AG
Sofrigam SA Ltd.
American Aerogel Corporation
EcoCool GmbH
Aeris Group
Dokasch
HAZGO
Beijing Roloo Technology
Insulated Products Corporation
Inmark Packaging
Guangzhou CCTS
Exeltainer SL
Cool Pac
Cryo Store
Biocair Customs
UPS


タイプ別
Single Use
Reusable


用途別
Temperature-Sensitive Pharmaceuticals
Vaccines
Blood Product
Others


製品カテゴリー


市場セグメント


地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界の医薬品温度管理包装市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：医薬品温度管理包装の定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：医薬品温度管理包装メーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：医薬品温度管理包装の生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでの医薬品温度管理包装の消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：医薬品温度管理包装に基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別に医薬品温度管理包装の市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：医薬品温度管理包装の主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：医薬品温度管理包装の上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：医薬品温度管理包装市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

The global Temperature Controlled Package for Pharmaceutical market was valued at US$ 6512 million in 2025 and is anticipated to reach US$ 11720 million by 2032, at a CAGR of 8.9% from 2026 to 2032.

In the pharmaceutical industry, the quality of pharmaceutical products has a direct effect on patient safety and the efficacy of patient therapies. Temperature Controlled Package for Pharmaceutical is designed for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. Temperature-controlled packaging solutions for pharmaceuticals are an important tool in reducing the risk and maintaining quality of product throughout the supply chain process by stabilizing internal temperature. This system helps to safeguard shipments across every aspect of the medical supply chain.

The Pharmaceuticals Temperature Controlled Packaging market is primarily driven by the growing demand for biologics, vaccines, and other temperature-sensitive drugs. These medications require strict temperature regulation to maintain their efficacy and safety, which has led to an increased focus on reliable and efficient packaging solutions. With the rise in global distribution of pharmaceuticals, particularly driven by COVID-19 vaccines and other biologic treatments, the need for advanced temperature-controlled packaging systems has surged, ensuring products maintain their required temperature during transit.

One of the key challenges for this market is the high cost associated with temperature-controlled packaging systems. The materials, technologies, and infrastructure required to ensure proper thermal insulation and monitoring of temperature-sensitive drugs are expensive, which can increase the overall cost of the pharmaceutical supply chain. Smaller companies and those operating in developing regions often struggle to afford such sophisticated packaging solutions, which can limit the accessibility of critical medicines.

The market also faces growing regulatory and environmental pressures. Stringent guidelines from regulatory bodies like the FDA and EMA require adherence to specific standards for packaging used in transporting pharmaceuticals. Additionally, there is increasing scrutiny on the environmental impact of these packaging materials, as many of them are non-recyclable or have a high carbon footprint. Balancing regulatory compliance with sustainability concerns poses a significant challenge for manufacturers in the sector.

There are lot of market players in the global Pharmaceuticals Temperature Controlled Packaging market, thus it’s tremendously fragmented. The large firms face hurdles as a result of high market fragmentation, which prevents them from growing into other markets or countries.

This report delivers a comprehensive overview of the global Temperature Controlled Package for Pharmaceutical market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Temperature Controlled Package for Pharmaceutical. The Temperature Controlled Package for Pharmaceutical market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Temperature Controlled Package for Pharmaceutical market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Temperature Controlled Package for Pharmaceutical manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
Sonoco Products Company
Envirotainer
Pelican Biothermal
Cryopak
DS Smith Pharma
Cold Chain Technologies
Intelsius
CSafe
Softbox Systems
Cencora
Skycell
Va-Q-tec AG
Sofrigam SA Ltd.
American Aerogel Corporation
EcoCool GmbH
Aeris Group
Dokasch
HAZGO
Beijing Roloo Technology
Insulated Products Corporation
Inmark Packaging
Guangzhou CCTS
Exeltainer SL
Cool Pac
Cryo Store
Biocair Customs
UPS

Segment by Type
Single Use
Reusable

Segment by Application
Temperature-Sensitive Pharmaceuticals
Vaccines
Blood Product
Others

By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Temperature Controlled Package for Pharmaceutical companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Temperature Controlled Package for Pharmaceutical Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Single Use
1.2.3 Reusable
1.3 Market by Application
1.3.1 Global Temperature Controlled Package for Pharmaceutical Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Temperature-Sensitive Pharmaceuticals
1.3.3 Vaccines
1.3.4 Blood Product
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Temperature Controlled Package for Pharmaceutical Market Perspective (2021–2032)
2.2 Global Temperature Controlled Package for Pharmaceutical Growth Trends by Region
2.2.1 Global Temperature Controlled Package for Pharmaceutical Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Temperature Controlled Package for Pharmaceutical Historic Market Size by Region (2021–2026)
2.2.3 Temperature Controlled Package for Pharmaceutical Forecasted Market Size by Region (2027–2032)
2.3 Temperature Controlled Package for Pharmaceutical Market Dynamics
2.3.1 Temperature Controlled Package for Pharmaceutical Industry Trends
2.3.2 Temperature Controlled Package for Pharmaceutical Market Drivers
2.3.3 Temperature Controlled Package for Pharmaceutical Market Challenges
2.3.4 Temperature Controlled Package for Pharmaceutical Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Temperature Controlled Package for Pharmaceutical Players by Revenue
3.1.1 Global Top Temperature Controlled Package for Pharmaceutical Players by Revenue (2021–2026)
3.1.2 Global Temperature Controlled Package for Pharmaceutical Revenue Market Share by Players (2021–2026)
3.2 Global Top Temperature Controlled Package for Pharmaceutical Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Temperature Controlled Package for Pharmaceutical Revenue
3.4 Global Temperature Controlled Package for Pharmaceutical Market Concentration Ratio
3.4.1 Global Temperature Controlled Package for Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Temperature Controlled Package for Pharmaceutical Revenue in 2025
3.5 Global Key Players of Temperature Controlled Package for Pharmaceutical Head Offices and Areas Served
3.6 Global Key Players of Temperature Controlled Package for Pharmaceutical, Products and Applications
3.7 Global Key Players of Temperature Controlled Package for Pharmaceutical, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans

4 Temperature Controlled Package for Pharmaceutical Breakdown Data by Type
4.1 Global Temperature Controlled Package for Pharmaceutical Historic Market Size by Type (2021–2026)
4.2 Global Temperature Controlled Package for Pharmaceutical Forecasted Market Size by Type (2027–2032)

5 Temperature Controlled Package for Pharmaceutical Breakdown Data by Application
5.1 Global Temperature Controlled Package for Pharmaceutical Historic Market Size by Application (2021–2026)
5.2 Global Temperature Controlled Package for Pharmaceutical Forecasted Market Size by Application (2027–2032)

6 North America
6.1 North America Temperature Controlled Package for Pharmaceutical Market Size (2021–2032)
6.2 North America Temperature Controlled Package for Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Temperature Controlled Package for Pharmaceutical Market Size by Country (2021–2026)
6.4 North America Temperature Controlled Package for Pharmaceutical Market Size by Country (2027–2032)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe Temperature Controlled Package for Pharmaceutical Market Size (2021–2032)
7.2 Europe Temperature Controlled Package for Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Temperature Controlled Package for Pharmaceutical Market Size by Country (2021–2026)
7.4 Europe Temperature Controlled Package for Pharmaceutical Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland

8 Asia-Pacific
8.1 Asia-Pacific Temperature Controlled Package for Pharmaceutical Market Size (2021–2032)
8.2 Asia-Pacific Temperature Controlled Package for Pharmaceutical Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Temperature Controlled Package for Pharmaceutical Market Size by Region (2021–2026)
8.4 Asia-Pacific Temperature Controlled Package for Pharmaceutical Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand

9 Latin America
9.1 Latin America Temperature Controlled Package for Pharmaceutical Market Size (2021–2032)
9.2 Latin America Temperature Controlled Package for Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Temperature Controlled Package for Pharmaceutical Market Size by Country (2021–2026)
9.4 Latin America Temperature Controlled Package for Pharmaceutical Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Temperature Controlled Package for Pharmaceutical Market Size (2021–2032)
10.2 Middle East & Africa Temperature Controlled Package for Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Temperature Controlled Package for Pharmaceutical Market Size by Country (2021–2026)
10.4 Middle East & Africa Temperature Controlled Package for Pharmaceutical Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 Sonoco Products Company
11.1.1 Sonoco Products Company Company Details
11.1.2 Sonoco Products Company Business Overview
11.1.3 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Introduction
11.1.4 Sonoco Products Company Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.1.5 Sonoco Products Company Recent Development
11.2 Envirotainer
11.2.1 Envirotainer Company Details
11.2.2 Envirotainer Business Overview
11.2.3 Envirotainer Temperature Controlled Package for Pharmaceutical Introduction
11.2.4 Envirotainer Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.2.5 Envirotainer Recent Development
11.3 Pelican Biothermal
11.3.1 Pelican Biothermal Company Details
11.3.2 Pelican Biothermal Business Overview
11.3.3 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Introduction
11.3.4 Pelican Biothermal Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.3.5 Pelican Biothermal Recent Development
11.4 Cryopak
11.4.1 Cryopak Company Details
11.4.2 Cryopak Business Overview
11.4.3 Cryopak Temperature Controlled Package for Pharmaceutical Introduction
11.4.4 Cryopak Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.4.5 Cryopak Recent Development
11.5 DS Smith Pharma
11.5.1 DS Smith Pharma Company Details
11.5.2 DS Smith Pharma Business Overview
11.5.3 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Introduction
11.5.4 DS Smith Pharma Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.5.5 DS Smith Pharma Recent Development
11.6 Cold Chain Technologies
11.6.1 Cold Chain Technologies Company Details
11.6.2 Cold Chain Technologies Business Overview
11.6.3 Cold Chain Technologies Temperature Controlled Package for Pharmaceutical Introduction
11.6.4 Cold Chain Technologies Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.6.5 Cold Chain Technologies Recent Development
11.7 Intelsius
11.7.1 Intelsius Company Details
11.7.2 Intelsius Business Overview
11.7.3 Intelsius Temperature Controlled Package for Pharmaceutical Introduction
11.7.4 Intelsius Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.7.5 Intelsius Recent Development
11.8 CSafe
11.8.1 CSafe Company Details
11.8.2 CSafe Business Overview
11.8.3 CSafe Temperature Controlled Package for Pharmaceutical Introduction
11.8.4 CSafe Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.8.5 CSafe Recent Development
11.9 Softbox Systems
11.9.1 Softbox Systems Company Details
11.9.2 Softbox Systems Business Overview
11.9.3 Softbox Systems Temperature Controlled Package for Pharmaceutical Introduction
11.9.4 Softbox Systems Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.9.5 Softbox Systems Recent Development
11.10 Cencora
11.10.1 Cencora Company Details
11.10.2 Cencora Business Overview
11.10.3 Cencora Temperature Controlled Package for Pharmaceutical Introduction
11.10.4 Cencora Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.10.5 Cencora Recent Development
11.11 Skycell
11.11.1 Skycell Company Details
11.11.2 Skycell Business Overview
11.11.3 Skycell Temperature Controlled Package for Pharmaceutical Introduction
11.11.4 Skycell Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.11.5 Skycell Recent Development
11.12 Va-Q-tec AG
11.12.1 Va-Q-tec AG Company Details
11.12.2 Va-Q-tec AG Business Overview
11.12.3 Va-Q-tec AG Temperature Controlled Package for Pharmaceutical Introduction
11.12.4 Va-Q-tec AG Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.12.5 Va-Q-tec AG Recent Development
11.13 Sofrigam SA Ltd.
11.13.1 Sofrigam SA Ltd. Company Details
11.13.2 Sofrigam SA Ltd. Business Overview
11.13.3 Sofrigam SA Ltd. Temperature Controlled Package for Pharmaceutical Introduction
11.13.4 Sofrigam SA Ltd. Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.13.5 Sofrigam SA Ltd. Recent Development
11.14 American Aerogel Corporation
11.14.1 American Aerogel Corporation Company Details
11.14.2 American Aerogel Corporation Business Overview
11.14.3 American Aerogel Corporation Temperature Controlled Package for Pharmaceutical Introduction
11.14.4 American Aerogel Corporation Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.14.5 American Aerogel Corporation Recent Development
11.15 EcoCool GmbH
11.15.1 EcoCool GmbH Company Details
11.15.2 EcoCool GmbH Business Overview
11.15.3 EcoCool GmbH Temperature Controlled Package for Pharmaceutical Introduction
11.15.4 EcoCool GmbH Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.15.5 EcoCool GmbH Recent Development
11.16 Aeris Group
11.16.1 Aeris Group Company Details
11.16.2 Aeris Group Business Overview
11.16.3 Aeris Group Temperature Controlled Package for Pharmaceutical Introduction
11.16.4 Aeris Group Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.16.5 Aeris Group Recent Development
11.17 Dokasch
11.17.1 Dokasch Company Details
11.17.2 Dokasch Business Overview
11.17.3 Dokasch Temperature Controlled Package for Pharmaceutical Introduction
11.17.4 Dokasch Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.17.5 Dokasch Recent Development
11.18 HAZGO
11.18.1 HAZGO Company Details
11.18.2 HAZGO Business Overview
11.18.3 HAZGO Temperature Controlled Package for Pharmaceutical Introduction
11.18.4 HAZGO Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.18.5 HAZGO Recent Development
11.19 Beijing Roloo Technology
11.19.1 Beijing Roloo Technology Company Details
11.19.2 Beijing Roloo Technology Business Overview
11.19.3 Beijing Roloo Technology Temperature Controlled Package for Pharmaceutical Introduction
11.19.4 Beijing Roloo Technology Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.19.5 Beijing Roloo Technology Recent Development
11.20 Insulated Products Corporation
11.20.1 Insulated Products Corporation Company Details
11.20.2 Insulated Products Corporation Business Overview
11.20.3 Insulated Products Corporation Temperature Controlled Package for Pharmaceutical Introduction
11.20.4 Insulated Products Corporation Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.20.5 Insulated Products Corporation Recent Development
11.21 Inmark Packaging
11.21.1 Inmark Packaging Company Details
11.21.2 Inmark Packaging Business Overview
11.21.3 Inmark Packaging Temperature Controlled Package for Pharmaceutical Introduction
11.21.4 Inmark Packaging Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.21.5 Inmark Packaging Recent Development
11.22 Guangzhou CCTS
11.22.1 Guangzhou CCTS Company Details
11.22.2 Guangzhou CCTS Business Overview
11.22.3 Guangzhou CCTS Temperature Controlled Package for Pharmaceutical Introduction
11.22.4 Guangzhou CCTS Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.22.5 Guangzhou CCTS Recent Development
11.23 Exeltainer SL
11.23.1 Exeltainer SL Company Details
11.23.2 Exeltainer SL Business Overview
11.23.3 Exeltainer SL Temperature Controlled Package for Pharmaceutical Introduction
11.23.4 Exeltainer SL Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.23.5 Exeltainer SL Recent Development
11.24 Cool Pac
11.24.1 Cool Pac Company Details
11.24.2 Cool Pac Business Overview
11.24.3 Cool Pac Temperature Controlled Package for Pharmaceutical Introduction
11.24.4 Cool Pac Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.24.5 Cool Pac Recent Development
11.25 Cryo Store
11.25.1 Cryo Store Company Details
11.25.2 Cryo Store Business Overview
11.25.3 Cryo Store Temperature Controlled Package for Pharmaceutical Introduction
11.25.4 Cryo Store Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.25.5 Cryo Store Recent Development
11.26 Biocair Customs
11.26.1 Biocair Customs Company Details
11.26.2 Biocair Customs Business Overview
11.26.3 Biocair Customs Temperature Controlled Package for Pharmaceutical Introduction
11.26.4 Biocair Customs Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.26.5 Biocair Customs Recent Development
11.27 UPS
11.27.1 UPS Company Details
11.27.2 UPS Business Overview
11.27.3 UPS Temperature Controlled Package for Pharmaceutical Introduction
11.27.4 UPS Revenue in Temperature Controlled Package for Pharmaceutical Business (2021–2026)
11.27.5 UPS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer